nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—PTGS2—amyotrophic lateral sclerosis	0.569	1	CbGaD
Ketoprofen—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0461	CcSEcCtD
Ketoprofen—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0397	CcSEcCtD
Ketoprofen—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0096	0.0366	CcSEcCtD
Ketoprofen—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.00918	0.035	CcSEcCtD
Ketoprofen—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00824	0.0314	CcSEcCtD
Ketoprofen—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00648	0.0247	CcSEcCtD
Ketoprofen—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00608	0.0232	CcSEcCtD
Ketoprofen—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0168	CcSEcCtD
Ketoprofen—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00423	0.0161	CcSEcCtD
Ketoprofen—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00391	0.0149	CcSEcCtD
Ketoprofen—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0143	CcSEcCtD
Ketoprofen—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00374	0.0143	CcSEcCtD
Ketoprofen—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00372	0.0142	CcSEcCtD
Ketoprofen—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0139	CcSEcCtD
Ketoprofen—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0139	CcSEcCtD
Ketoprofen—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00364	0.0139	CcSEcCtD
Ketoprofen—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0138	CcSEcCtD
Ketoprofen—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0133	CcSEcCtD
Ketoprofen—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0133	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00346	0.0132	CcSEcCtD
Ketoprofen—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00343	0.0131	CcSEcCtD
Ketoprofen—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0129	CcSEcCtD
Ketoprofen—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00335	0.0128	CcSEcCtD
Ketoprofen—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00328	0.0125	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00327	0.0125	CcSEcCtD
Ketoprofen—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0123	CcSEcCtD
Ketoprofen—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00316	0.012	CcSEcCtD
Ketoprofen—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00289	0.011	CcSEcCtD
Ketoprofen—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00282	0.0108	CcSEcCtD
Ketoprofen—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0106	CcSEcCtD
Ketoprofen—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00993	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00984	CcSEcCtD
Ketoprofen—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00981	CcSEcCtD
Ketoprofen—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00975	CcSEcCtD
Ketoprofen—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00948	CcSEcCtD
Ketoprofen—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00942	CcSEcCtD
Ketoprofen—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00937	CcSEcCtD
Ketoprofen—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00937	CcSEcCtD
Ketoprofen—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00922	CcSEcCtD
Ketoprofen—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00917	CcSEcCtD
Ketoprofen—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00907	CcSEcCtD
Ketoprofen—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00897	CcSEcCtD
Ketoprofen—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00865	CcSEcCtD
Ketoprofen—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00863	CcSEcCtD
Ketoprofen—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00859	CcSEcCtD
Ketoprofen—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00857	CcSEcCtD
Ketoprofen—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00816	CcSEcCtD
Ketoprofen—Chills—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00774	CcSEcCtD
Ketoprofen—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00771	CcSEcCtD
Ketoprofen—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.002	0.00763	CcSEcCtD
Ketoprofen—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0074	CcSEcCtD
Ketoprofen—Tension—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00737	CcSEcCtD
Ketoprofen—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00736	CcSEcCtD
Ketoprofen—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0073	CcSEcCtD
Ketoprofen—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00697	CcSEcCtD
Ketoprofen—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00694	CcSEcCtD
Ketoprofen—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00686	CcSEcCtD
Ketoprofen—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00677	CcSEcCtD
Ketoprofen—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00675	CcSEcCtD
Ketoprofen—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00664	CcSEcCtD
Ketoprofen—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00651	CcSEcCtD
Ketoprofen—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00649	CcSEcCtD
Ketoprofen—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0064	CcSEcCtD
Ketoprofen—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00637	CcSEcCtD
Ketoprofen—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00632	CcSEcCtD
Ketoprofen—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00626	CcSEcCtD
Ketoprofen—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00618	CcSEcCtD
Ketoprofen—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00613	CcSEcCtD
Ketoprofen—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00613	CcSEcCtD
Ketoprofen—Infection—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00609	CcSEcCtD
Ketoprofen—Shock—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00603	CcSEcCtD
Ketoprofen—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.006	CcSEcCtD
Ketoprofen—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00598	CcSEcCtD
Ketoprofen—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00593	CcSEcCtD
Ketoprofen—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00584	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00559	CcSEcCtD
Ketoprofen—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00555	CcSEcCtD
Ketoprofen—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00551	CcSEcCtD
Ketoprofen—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00547	CcSEcCtD
Ketoprofen—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00545	CcSEcCtD
Ketoprofen—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0054	CcSEcCtD
Ketoprofen—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00533	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00529	CcSEcCtD
Ketoprofen—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00529	CcSEcCtD
Ketoprofen—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00524	CcSEcCtD
Ketoprofen—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00505	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00501	CcSEcCtD
Ketoprofen—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00487	CcSEcCtD
Ketoprofen—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00485	CcSEcCtD
Ketoprofen—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00452	CcSEcCtD
Ketoprofen—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0044	CcSEcCtD
Ketoprofen—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00434	CcSEcCtD
Ketoprofen—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0042	CcSEcCtD
Ketoprofen—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00405	CcSEcCtD
Ketoprofen—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0039	CcSEcCtD
Ketoprofen—Rash—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00387	CcSEcCtD
Ketoprofen—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00386	CcSEcCtD
Ketoprofen—Headache—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00384	CcSEcCtD
Ketoprofen—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000954	0.00364	CcSEcCtD
Ketoprofen—Carprofen—PTGS2—amyotrophic lateral sclerosis	0.000944	0.109	CrCbGaD
Ketoprofen—Ketorolac—PTGS2—amyotrophic lateral sclerosis	0.000944	0.109	CrCbGaD
Ketoprofen—Bromfenac—PTGS2—amyotrophic lateral sclerosis	0.000905	0.105	CrCbGaD
Ketoprofen—Tiaprofenic acid—PTGS2—amyotrophic lateral sclerosis	0.00077	0.0889	CrCbGaD
Ketoprofen—Nepafenac—PTGS2—amyotrophic lateral sclerosis	0.000732	0.0846	CrCbGaD
Ketoprofen—Magnesium salicylate—PTGS2—amyotrophic lateral sclerosis	0.000716	0.0826	CrCbGaD
Ketoprofen—Fenbufen—PTGS2—amyotrophic lateral sclerosis	0.0007	0.0809	CrCbGaD
Ketoprofen—Salsalate—PTGS2—amyotrophic lateral sclerosis	0.000608	0.0703	CrCbGaD
Ketoprofen—Suprofen—PTGS2—amyotrophic lateral sclerosis	0.000583	0.0674	CrCbGaD
Ketoprofen—Fenoprofen—PTGS2—amyotrophic lateral sclerosis	0.000503	0.0581	CrCbGaD
Ketoprofen—Mefenamic acid—PTGS2—amyotrophic lateral sclerosis	0.000466	0.0539	CrCbGaD
Ketoprofen—Naproxen—PTGS2—amyotrophic lateral sclerosis	0.000458	0.0529	CrCbGaD
Ketoprofen—Flurbiprofen—PTGS2—amyotrophic lateral sclerosis	0.000328	0.0379	CrCbGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000195	0.00122	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000193	0.00121	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000193	0.0012	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000193	0.0012	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000193	0.0012	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00019	0.00118	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000187	0.00117	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000185	0.00116	CbGpPWpGaD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000184	0.00115	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000184	0.00115	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000183	0.00114	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	0.000183	0.00114	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000183	0.00114	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000182	0.00114	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000182	0.00114	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000182	0.00113	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000182	0.00113	CbGpPWpGaD
Ketoprofen—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000181	0.00113	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000179	0.00111	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000174	0.00109	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000174	0.00109	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000171	0.00107	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00017	0.00106	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00017	0.00106	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00017	0.00106	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00017	0.00106	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000168	0.00105	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000167	0.00104	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000166	0.00104	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000165	0.00103	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000164	0.00102	CbGpPWpGaD
Ketoprofen—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000163	0.00101	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000163	0.00101	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000162	0.00101	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000162	0.00101	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000161	0.00101	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000161	0.00101	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000161	0.001	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000161	0.001	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.00016	0.000999	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00016	0.000996	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000158	0.000987	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000157	0.00098	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000155	0.000969	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000155	0.000968	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000155	0.000966	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000152	0.000947	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000152	0.000947	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000151	0.00094	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—amyotrophic lateral sclerosis	0.00015	0.000935	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00015	0.000933	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000148	0.000921	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000146	0.000908	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000145	0.000902	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000144	0.000898	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000144	0.000898	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000143	0.00089	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000139	0.000867	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000139	0.000864	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000139	0.000864	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000138	0.000863	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000137	0.000852	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000135	0.000844	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000135	0.000844	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000134	0.000835	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000133	0.000828	CbGpPWpGaD
Ketoprofen—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000132	0.000825	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000132	0.000821	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	0.000131	0.000819	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000131	0.000818	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000131	0.000816	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000129	0.000806	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000128	0.000795	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000127	0.000793	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000127	0.00079	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000126	0.000783	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000124	0.000776	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000121	0.000757	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000119	0.000739	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000118	0.000735	CbGpPWpGaD
Ketoprofen—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000117	0.000728	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000115	0.000719	CbGpPWpGaD
Ketoprofen—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000115	0.000718	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000115	0.000718	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000111	0.000692	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000111	0.000691	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00011	0.000687	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00011	0.000686	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00011	0.000686	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000109	0.000683	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000108	0.000675	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000107	0.000669	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	0.000105	0.000655	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000104	0.000647	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000103	0.000641	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000103	0.00064	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000103	0.00064	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000101	0.000633	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000101	0.000627	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.0001	0.000625	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	9.98e-05	0.000622	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	9.95e-05	0.00062	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.93e-05	0.000619	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	9.74e-05	0.000607	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.54e-05	0.000595	CbGpPWpGaD
Ketoprofen—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.51e-05	0.000593	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	9.49e-05	0.000592	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—TP53—amyotrophic lateral sclerosis	9.49e-05	0.000592	CbGpPWpGaD
Ketoprofen—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.37e-05	0.000585	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.35e-05	0.000583	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	9.33e-05	0.000582	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	9.28e-05	0.000579	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	9.21e-05	0.000574	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.96e-05	0.000559	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	8.95e-05	0.000558	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	8.95e-05	0.000558	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	8.9e-05	0.000555	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	8.9e-05	0.000555	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	8.82e-05	0.00055	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.82e-05	0.00055	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	8.79e-05	0.000548	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	8.74e-05	0.000545	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	8.73e-05	0.000545	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.72e-05	0.000544	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	8.57e-05	0.000535	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.43e-05	0.000526	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.39e-05	0.000523	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.34e-05	0.00052	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	8.33e-05	0.000519	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.3e-05	0.000518	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	8.25e-05	0.000514	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	8.19e-05	0.000511	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	8.14e-05	0.000508	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	7.96e-05	0.000496	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	7.95e-05	0.000496	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.89e-05	0.000492	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.89e-05	0.000492	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.85e-05	0.00049	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	7.7e-05	0.000481	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.61e-05	0.000475	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	7.59e-05	0.000474	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.57e-05	0.000472	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	7.56e-05	0.000472	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.29e-05	0.000455	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	7.28e-05	0.000454	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	7.28e-05	0.000454	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	7.2e-05	0.000449	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	7.17e-05	0.000447	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	7.15e-05	0.000446	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	7.11e-05	0.000444	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.09e-05	0.000442	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.03e-05	0.000439	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	7.01e-05	0.000437	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.9e-05	0.00043	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	6.79e-05	0.000424	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.79e-05	0.000424	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	6.76e-05	0.000422	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	6.66e-05	0.000416	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.49e-05	0.000405	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	6.47e-05	0.000404	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.44e-05	0.000402	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	6.43e-05	0.000401	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	6.41e-05	0.0004	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.38e-05	0.000398	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.35e-05	0.000396	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.19e-05	0.000386	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.03e-05	0.000376	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.99e-05	0.000374	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	5.98e-05	0.000373	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	5.94e-05	0.00037	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	5.82e-05	0.000363	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.75e-05	0.000359	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.62e-05	0.00035	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	5.56e-05	0.000347	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.39e-05	0.000336	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.35e-05	0.000334	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	5.27e-05	0.000328	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.25e-05	0.000327	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.07e-05	0.000316	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	5.02e-05	0.000313	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.99e-05	0.000311	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	4.9e-05	0.000306	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	4.88e-05	0.000304	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.73e-05	0.000295	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.72e-05	0.000294	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	4.6e-05	0.000287	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.58e-05	0.000286	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.57e-05	0.000285	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	4.53e-05	0.000282	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	4.5e-05	0.000281	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	4.5e-05	0.000281	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.42e-05	0.000276	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.31e-05	0.000269	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.24e-05	0.000264	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.17e-05	0.00026	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.12e-05	0.000257	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.1e-05	0.000256	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.07e-05	0.000254	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.06e-05	0.000254	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	3.99e-05	0.000249	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	3.88e-05	0.000242	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.81e-05	0.000237	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.74e-05	0.000233	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	3.72e-05	0.000232	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	3.7e-05	0.00023	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	3.68e-05	0.00023	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.6e-05	0.000224	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.54e-05	0.000221	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.39e-05	0.000212	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.37e-05	0.00021	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.35e-05	0.000209	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	3.35e-05	0.000209	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	3.34e-05	0.000208	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.2e-05	0.0002	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.09e-05	0.000193	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.07e-05	0.000192	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.06e-05	0.000191	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	3.02e-05	0.000189	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.93e-05	0.000183	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	2.86e-05	0.000179	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.84e-05	0.000177	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.76e-05	0.000172	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.45e-05	0.000153	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	2.34e-05	0.000146	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.32e-05	0.000145	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.31e-05	0.000144	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.26e-05	0.000141	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.25e-05	0.000141	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	2.22e-05	0.000138	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.13e-05	0.000133	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.11e-05	0.000131	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2e-05	0.000125	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2e-05	0.000125	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.99e-05	0.000124	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.91e-05	0.000119	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.89e-05	0.000118	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	1.86e-05	0.000116	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.84e-05	0.000114	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.83e-05	0.000114	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.63e-05	0.000101	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.6e-05	9.99e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.51e-05	9.42e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.51e-05	9.42e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.5e-05	9.37e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.49e-05	9.32e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.44e-05	9.01e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.23e-05	7.67e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.03e-05	6.45e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.03e-05	6.42e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.42e-06	5.25e-05	CbGpPWpGaD
